サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451343

ニキビ治療薬市場レポート：にきびタイプ別、薬剤クラス別、薬剤タイプ別、投与経路別、地域別、2024-2032

Acne Drugs Market Report by Acne Type, Drug Class, Drug Type, Route of Administration, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ニキビ治療薬市場レポート：にきびタイプ別、薬剤クラス別、薬剤タイプ別、投与経路別、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニキビ治療薬市場規模は2023年に69億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて5.2%の成長率（CAGR）を示し、2032年までに109億米ドルに達すると予測しています。青少年や成人におけるニキビの有病率の増加、スキンケアに対する意識の高まりと重視、革新的な治療につながる医薬品の研究開発の進歩、新興国における可処分所得の増加、スキンケアの動向に対するソーシャルメディアの影響などが、市場の成長を促進しています。

ニキビ治療薬は、ニキビ（吹き出物、黒ずみ、白斑、炎症を特徴とする一般的な皮膚疾患）の症状を管理・緩和するために特別に設計された医薬品または一般用医薬品（OTC）です。これらの医薬品はスキンケア業界において極めて重要であり、ニキビに関連する懸念の緩和を求める人々にとって主要な情報源となっています。ニキビ治療薬の利点には、炎症を抑え、毛穴の詰まりを取り除き、油の分泌をコントロールし、最終的にはより透明で健康的な肌を促進する能力があることが挙げられます。ニキビ治療薬は、皮膚の状態を管理し改善しようとする人々に貴重なリソースを提供し、皮膚科学とスキンケアの領域におけるこれらの治療法の重要性を強調しています。ニキビ治療薬には様々な種類があり、主に外用薬と内服薬に分類されます。外用薬は通常、クリーム、ジェル、ローションなどの形で、患部の皮膚に直接塗布します。一方、内服薬は摂取し、内服することでニキビと闘います。

世界のニキビ治療薬市場は、世界中の青少年や成人の間でニキビの有病率が増加していることに影響を受けています。これはさらに、スキンケアと外見に対する意識の高まりと重視によって支えられています。さらに、革新的でより効率的なニキビ治療薬のイントロダクションつながる医薬品の研究開発の進歩が、市場の拡大に寄与しています。さらに、新興国における可処分所得水準の上昇は、消費者にニキビ治療製品への投資を促し、これが市場の成長を増大させています。さらに、ソーシャルメディアや有名人によるスキンケア製品の推薦の影響が市場成長を刺激しています。これとは別に、化粧品産業の拡大や、個人に合わせたスキンケアソリューションのトレンドが市場成長を加速させています。

ニキビ治療薬の市場動向と促進要因：

ニキビ有病率の増加

ニキビ治療薬の世界市場は、世界中の青少年や成人の間でニキビの有病率が上昇していることから、大幅な急成長を遂げています。ニキビは、吹き出物、黒ずみ、白斑の形成を特徴とする一般的な皮膚疾患であり、世界中の何百万人もの人々が罹患しています。このようなニキビ症例の急増は、思春期におけるホルモンの変化、ストレスレベルの上昇、食生活の乱れや不十分なスキンケア習慣などの生活習慣など、さまざまな要因が主な原因となっています。その結果、この広範な懸念に対処するための効果的なニキビ治療オプションに対する需要が高まっています。このような背景から、製薬企業は多様な患者層に対応する革新的で信頼性が高く、利用しやすいニキビ治療薬を開発・提供することが急務となっており、世界のニキビ治療薬市場の成長に拍車をかけています。

スキンケアに対する意識の高まりと重視

世界のニキビ治療薬市場のもう一つの重要な促進要因は、スキンケアや身だしなみに対する意識の高まりと重視です。イメージ重視の現代社会では、透明でシミのない肌を実現するためにスキンケア製品や治療法に投資する傾向が強まっています。このような意識の高まりは、完璧な肌が理想的な基準として描かれることの多いソーシャルメディアの影響によるものです。その結果、消費者はニキビを管理・治療するソリューションをより積極的に求めるようになった。このようなニキビ治療薬や治療法に対する需要の高まりから、個人は皮膚の健康と見た目を向上させるために幅広い製品や治療法を積極的に検討するようになり、市場の堅調な成長に寄与しています。

医薬品研究開発の進歩

世界のニキビ治療薬市場は、医薬品の研究開発（R&D）の継続的な進歩によって大きく後押しされています。製薬会社は、ニキビ治療のための革新的でより効率的な製剤の開発に積極的に取り組んでいます。これらの進歩は、新規有効成分の発見、ドラッグデリバリー・システムの改良、ニキビの病態生理の複数の側面を標的とする併用療法の開発など、様々な側面を包含しています。このような技術革新は、より安全で、より効果的で、より即効性のあるニキビ治療薬のイントロダクションをもたらし、最終的には患者の進化するニーズに応えることになります。さらに、副作用の少ない外用薬や経口薬の開発は、研究開発努力の進歩の証です。その結果、これらの技術革新は、ニキビを効果的に管理するための優れた治療選択肢を医療従事者や患者に提供することで、市場の成長を促進しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のニキビ治療薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：ニキビタイプ別

  • コメド
    • 市場動向
    • 市場予測
  • 炎症性
    • 市場動向
    • 市場予測
  • 嚢胞性
    • 市場動向
    • 市場予測
  • 術後/創傷
    • 市場動向
    • 市場予測

第7章 市場内訳：薬剤クラス別

  • レチノイド
    • 市場動向
    • 市場予測
  • 抗生物質
    • 市場動向
    • 市場予測
  • ホルモン剤
    • 市場動向
    • 市場予測
  • 配合剤
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：医薬品タイプ別

  • 一般用医薬品
    • 市場動向
    • 市場予測
  • 処方薬
    • 市場動向
    • 市場予測

第9章 市場内訳：投与経路別

  • 外用薬
    • 市場動向
    • 市場予測
  • 経口剤
    • 市場動向
    • 市場予測
  • 注射剤
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2023
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million US$), 2024-2032
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players
目次
Product Code: SR112024A2359

The global acne drugs market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Increasing prevalence of acne among adolescents and adults, growing awareness and emphasis on skincare, advancements in pharmaceutical R&D leading to innovative treatments, rising disposable incomes in emerging economies, and social media influence on skincare trends are facilitating the market growth.

Acne drugs are pharmaceutical or over-the-counter (OTC) products specifically designed to manage and alleviate the symptoms of acne, a common skin condition characterized by the presence of pimples, blackheads, whiteheads, and inflammation. These medications are pivotal in the skincare industry and serve as a primary resource for individuals seeking relief from acne-related concerns. Advantages of acne drugs include their ability to reduce inflammation, unclog pores, control oil production, and ultimately promote clearer, healthier skin. They offer a valuable resource for individuals seeking to manage and improve their skin condition, underlining the significance of these treatments in the realm of dermatology and skincare. There are various types of acne drugs available, primarily categorized into topical and oral treatments. Topical medications typically come in the form of creams, gels, or lotions and are applied directly to the affected skin. On the other hand, oral medications are ingested and work internally to combat acne.

The global acne drugs market is influenced by the increasing prevalence of acne among adolescents and adults worldwide. This is further supported by the growing awareness and emphasis on skincare and appearance. Moreover, advancements in pharmaceutical research and development, leading to the introduction of innovative and more efficient acne drug formulations, contribute to market expansion. Additionally, the rise in disposable income levels in emerging economies empowers consumers to invest in acne treatment products, which, in turn, is augmenting the market growth. Furthermore, the influence of social media and celebrity endorsements of skincare products is stimulating the market growth. Apart from this, the expanding cosmetic industry and the trend towards personalized skincare solutions are accelerating the market growth.

Acne Drugs Market Trends/Drivers:

Increasing prevalence of acne

The global acne drugs market is witnessing a substantial surge due to the escalating prevalence of acne among adolescents and adults worldwide. Acne, a common skin condition characterized by the formation of pimples, blackheads, and whiteheads, affects millions of individuals across the globe. This surge in acne cases is primarily attributed to various factors, including hormonal changes during puberty, increased stress levels, and lifestyle factors such as poor diet and inadequate skincare routines. As a result, there is a growing demand for effective acne treatment options to address this widespread concern. This driver underscores the urgent need for pharmaceutical companies to develop and provide innovative, reliable, and accessible acne medications that cater to diverse patient populations, thereby fueling the growth of the global acne drugs market.

Growing awareness and emphasis on skincare

Another critical driver of the global acne drugs market is the growing awareness and emphasis on skincare and personal appearance. In today's image-conscious society, individuals are increasingly inclined to invest in skincare products and treatments to achieve clear and blemish-free skin. This heightened awareness is driven by the influence of social media, where flawless skin is often portrayed as an ideal standard. As a result, consumers are more proactive in seeking solutions to manage and treat acne. The market benefits from this heightened demand for acne drugs and treatments, as individuals are willing to explore a wide range of products and therapies to enhance their skin's health and appearance, thus contributing to the market's robust growth.

Advancements in pharmaceutical research and development

The global acne drugs market is significantly propelled by continuous advancements in pharmaceutical research and development (R&D). Pharmaceutical companies are actively engaged in developing innovative and more efficient formulations for acne treatment. These advancements encompass various aspects, including the discovery of novel active ingredients, improved drug delivery systems, and the development of combination therapies that target multiple aspects of acne's pathophysiology. Such innovations result in the introduction of safer, more effective, and faster-acting acne drugs, ultimately meeting the evolving needs of patients. Furthermore, the development of topical and oral medications with fewer side effects is a testament to the progress made in R&D efforts. Consequently, these innovations drive market growth by providing healthcare professionals and patients with superior treatment options for managing acne effectively.

Acne Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global acne drugs market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on acne type, drug class, drug type, and route of administration.

Breakup by Acne Type:

Comedonal

Inflammatory

Cystic

Postsurgical/Wound

A detailed breakup and analysis of the market based on the acne type has been provided in the report. This includes comedonal, inflammatory, cystic, and postsurgical/wound.

For the comedonal segment, key drivers include the surging prevalence of non-inflammatory acne cases, rising awareness among individuals regarding mild acne treatment, increased accessibility to over-the-counter remedies, pharmaceutical companies' focus on targeted solutions, and the pursuit of clear, blemish-free skin. In the Inflammatory segment, drivers encompass the demand for potent anti-inflammatory agents, growing cases of moderate to severe acne, continuous research efforts to develop effective solutions, dermatologist recommendations, and the influence of social media on seeking medical-grade treatments. Cystic acne's drivers revolve around its severity, leading to a higher demand for prescription-based medications, the need for specialized treatments, increased patient awareness, emerging innovative therapies, and the aspiration to prevent scarring. Postsurgical/wound acne treatment segment is driven by factors such as the need for post-procedure skincare, the rise in cosmetic surgeries, scar prevention, dermatologist prescriptions, and the emphasis on post-surgical recovery and aesthetics.

Breakup by Drug Class:

Retinoids

Antibiotics

Hormonal Agents

Combination Drugs

Others

Retinoids dominate the market

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes retinoids, antibiotics, hormonal agents, combination drugs, and others. According to the report, retinoids represented the largest segment.

The retinoids segment within the global acne drugs market is driven by the surging awareness regarding the advantages of retinoids in acne treatment. Their efficacy lies in their ability to regulate skin cell turnover, prevent the formation of comedones (blackheads and whiteheads), and reduce inflammation. This proven track record makes retinoids a go-to choice for both healthcare professionals and individuals seeking reliable acne solutions. Furthermore, retinoids have garnered widespread dermatologist endorsement, underlining their credibility and medical backing. Dermatologists often prescribe retinoids, either in topical or oral form, for various acne types, especially for moderate to severe cases. Another driving factor is the continuous innovation in retinoid formulations. Pharmaceutical companies are investing in research and development to enhance the tolerability and effectiveness of retinoid-based treatments, reducing side effects commonly associated with them. Moreover, the demand for retinoids extends beyond acne treatment, as they are also recognized for their anti-aging properties, further expanding their market reach. This dual functionality appeals to a broader consumer base.

Breakup by Drug Type:

OTC Drugs

Prescription Drugs

A detailed breakup and analysis of the market based on the drug type has also been provided in the report. This includes OTC drugs and prescription drugs.

Over-the-counter (OTC) drugs segment are witnessing substantial growth, driven by their easy accessibility and the increasing preference for self-care solutions. Consumers appreciate the convenience of obtaining these medications without prescriptions, enabling them to manage mild to moderate acne independently. The growing trend of self-care further bolsters their popularity, with individuals seeking swift remedies for common skin concerns, readily available at pharmacies, supermarkets, and online outlets. On the other hand, the prescription drugs segment thrives on dermatologist recommendations and the severity of acne cases. Dermatologists, recognized authorities in skin conditions, frequently prescribe potent, tailored medications for moderate to severe acne cases. This professional endorsement significantly influences patients' choices, directing them towards prescription drugs. These specialized formulations are designed to address specific skin issues effectively. As a result, the demand for prescription-based solutions remains robust, contributing significantly to the growth of this segment.

Breakup by Route of Administration:

Topical

Oral

Injectable

Topical holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes topical, oral, and injectable. According to the report, topical represented the largest segment.

The topical segment within the global acne drugs market is driven by the convenience of topical treatments plays a significant role, as these products are easy to apply directly to affected areas, making them a preferred choice for many individuals seeking localized acne management. Moreover, the efficacy and safety of topicals have improved over the years, thanks to continuous advancements in pharmaceutical research and development, leading to formulations with fewer side effects and better outcomes. In line with this, dermatologist recommendations heavily influence the topical segment, as medical professionals often prescribe specific topical medications tailored to a patient's unique skin condition. Furthermore, the broad range of topicals available, including creams, gels, and lotions, provides options that cater to various skin types and preferences. Additionally, the accessibility of over-the-counter (OTC) topical acne treatments contributes to the segment's growth, enabling individuals to address mild to moderate acne issues independently. Apart from this, the increasing awareness of skincare and the desire for clear, blemish-free skin further propel the demand for topical acne treatments, emphasizing their integral role in the global market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest acne drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's acne drugs market is influenced by several key factors, including the region's high prevalence of acne among adolescents and adults, underlining the demand for effective treatments. Furthermore, advanced healthcare infrastructure and accessibility to dermatologists and medical professionals enhance diagnosis and prescription of acne medications. In line with this, a robust consumer inclination towards skincare and appearance maintenance contributes to market growth. This is further supported by the prevalence of a well-established cosmetic and pharmaceutical industry, which fosters innovation and product development in the acne drugs sector. Moreover, awareness campaigns and skincare education initiatives play a crucial role in creating a proactive approach toward acne management. Additionally, regulatory support and stringent quality standards in North America ensure the safety and efficacy of acne drugs, further bolstering consumer trust in the market.

Competitive Landscape:

The competitive landscape of the global acne drugs market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative and effective solutions for acne treatment. While specific players are not mentioned here due to the user's request, it's important to note that the market fosters competition through research and development, strategic collaborations, and product diversification. Companies within this space are continually investing in R&D to formulate new medications and therapies that target various types of acne, ranging from mild to severe cases. Partnerships with dermatologists and skincare experts help in endorsing their products, adding credibility and market reach. Furthermore, marketing strategies, including digital marketing and social media, play a pivotal role in promoting their products and educating consumers about effective acne management. The competitive landscape emphasizes the importance of quality, safety, and innovation in addressing the diverse needs of individuals seeking acne treatments, ultimately benefiting consumers with a wider range of options and improved solutions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Allergan Plc

Bausch Health Companies Inc.

Bayer Aktiengesellschaft

Cipher Pharmaceuticals Inc.

Galderma Holding SA

Johnson & Johnson

Pfizer Inc.

Reckitt Benckiser Group Plc

Skinvisible Pharmaceuticals Inc.

Sun Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In May 2023, Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA).

In June 2023, Sun Pharmaceutical Industries Ltd, received approval of Health Canada, the country's health regulator, for its WINLEVI cream, used in treating certain skin ailments.

In September 2023, Marksans Pharma completed the acquisition of Teva Pharmaceuticals in India to continue providing an uninterrupted supply of Teva's important medicines to customers and patients.

Key Questions Answered in This Report

  • 1. How big is the global acne drugs market?
  • 2. What is the expected growth rate of the global acne drugs market during 2024-2032?
  • 3. What are the key factors driving the global acne drugs market?
  • 4. What has been the impact of COVID-19 on the global acne drugs market?
  • 5. What is the breakup of the global acne drugs market based on the drug class?
  • 6. What is the breakup of the global acne drugs market based on the route of administration?
  • 7. What are the key regions in the global acne drugs market?
  • 8. Who are the key players/companies in the global acne drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis